logo-loader
viewBlueJay Mining PLC

BlueJay Mining says PFS underlines huge potential of Dundas project in Greenland

"The base case positive 32.8% IRR and US$83.1MM NPV are just a starting point"

paint
Ilmenite/titanium is used for paint pigments

BlueJay Mining PLC’s (LON:JAY) Dundas minerals sands project in Greenland is worth US$83mln over a nine-year mine life according to a pre-feasibility study. 

Costs to build the mine and infrastructure are estimated at US$245mln.

BlueJay added that the PFS was based only on a JORC compliant mineral reserve of 67.1Mt and not the entire resource of 117Mt and designed both as a high-level assessment of Dundas and to accelerate the permitting process.

The cut-off grade used assumed a selling price of US$232/t, all in sustaining costs of US$113/t, Greenland royalty of 2.5% and total titanium dioxide recovery of 79.7%

Roderick McIllree, the junior's chief executive, said the PFS demonstrated  Dundas' commerciality. while there was plenty of scope to improve the numbers through resources to reserve work.

"The base case positive 32.8% IRR and US$83.1MM NPV are just a starting point. With demonstrable potential for additional resources both on and offshore along the entire 30km of licence holdings the opportunity to significantly increase the initial 9-year mine life and/or rate of production is clear."

McIllree said he was also confident the construction costs can be brought down materially and a detailed costing study will now get underway.

"To truly understand Dundas' worth, one must also look at the value it could add to higher grade finished products because of the potential for blending with lower quality feedstocks"

The PFS has been lodged with the Government of Greenland as part of an exploitation application while talks are underway with European funding agencies.

Quick facts: BlueJay Mining PLC

Price: 9.68 GBX

AIM:JAY
Market: AIM
Market Cap: £82.76 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of BlueJay Mining PLC named herein, including the promotion by the Company of BlueJay Mining PLC in any Content on the Site, the Company receives...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Investor Update: Allergy Therapeutics receives multi-million-dollar settlement

Top stories from the Proactive Investors UK newsroom. Allergy Therapeutics (LON:AGY) has accepted US$7.6mln in settlement of a dispute over the procedures used for a US grass pollen vaccine trial. Allergy blamed the inconclusive trial results on the way the study was carried...

on 27/6/19

2 min read